News | May 20, 2008

New Training Guidance Given for Implants of Cardiac Devices in Pediatrics

May 21, 2008 - The Heart Rhythm Society and the Pediatric Congenital Electrophysiology Society (PACES) have released the first training guidelines (PDF, 108K) for physician knowledge and experience for treating this unique patient population. The statement was released today at Heart Rhythm 2008, the Heart Rhythm Society’s 29th Annual Scientific Sessions.

As devices such as pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices become more advanced, these life-saving therapies are being used more frequently in pediatric and congenital heart patients.

The Heart Rhythm Society and PACES developed a task force comprised of adult and pediatric cardiologists as well as adult and pediatric surgeons to prepare the Heart Rhythm Society/PACES Clinical Competency Statement: Training pathways for implantation of cardioverter-defibrillators and cardiac resynchronization therapy devices in pediatric and congenital heart patients. The task force assessed implant volumes and physician background in 49 pediatric programs that implant pacemakers, ICDs and CRT devices, and these findings serve as a framework for the new recommendations.

“Healthcare teams involved in the care of these patients should have proper knowledge and expertise surrounding implantation indications, techniques, programming and follow-up of these devices, as well as the non-technical issues relevant to children,” said the statement’s lead author J. Philip Saul, MD, Professor and Chief of Pediatric Cardiology at the Medical University of South Carolina. “This statement complements prior training guidelines and also establishes new criteria for ICD and CRT implantation in pediatric patients as well as adults with congenital heart disease.”

For more information: www.hrsonline.org


Related Content

News | Implantable Cardioverter Defibrillator (ICD)

February 12, 2024 — BIOTRONIK, a leader in implantable medical device technology, announced today they will solely ...

Home February 12, 2024
Home
News | Implantable Cardioverter Defibrillator (ICD)

October 23, 2023 — Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug ...

Home October 23, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial ...

Home August 28, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 28, 2023 — Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and ...

Home August 28, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Medtronic ICDs and CRT-Ds ...

Home July 18, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...

Home March 07, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

February 17, 2023 — Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan ...

Home February 17, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...

Home August 29, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 18, 2022 — A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients ...

Home August 18, 2022
Home
Subscribe Now